Crossmark

Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1

Crossref DOI link: https://doi.org/10.1038/leu.2015.140

Published Online: 2015-05-15

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Teo, A E

Chen, Z

Miranda, R N

McDonnell, T

Medeiros, L J

McCarty, N
License Information

Text and Data Mining valid from 2015-05-15

Version of Record valid from 2015-05-15
More Information

Article History

Received: 4 March 2015

Revised: 6 May 2015

Accepted: 11 May 2015

First Online: 15 May 2015

Competing interests

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below